Insight Genetics Launches First-of-its-kind Test for Triple Negative Breast Cancer
4 December 2018
Insight Genetics, Inc. today announced the launch of its proprietary Insight TNBCtype™, a new test for categorizing triple negative breast cancer (TNBC) tumors into distinct molecular subtype
